Macclesfield, United Kingdom

Matt Wood

This inventor holds 1 USPTO granted patent. Top assignees: Astrazeneca Ab, Cancer Research Technology Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matt Wood. Retrieved from https://idiyas.com/inventor/matt-wood-03i5d48i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Matt Wood

Introduction

Matt Wood is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of chemical compounds. His work has the potential to impact the lives of many individuals affected by cancer.

Latest Patents

Matt Wood holds a patent for 1,3,4-thiadiazole compounds and their use in treating cancer. This patent, identified as a compound of Formula (I), showcases his dedication to advancing medical science and finding new solutions for complex health issues. He has 1 patent to his name, reflecting his commitment to innovation in the pharmaceutical field.

Career Highlights

Throughout his career, Matt Wood has worked with prominent organizations such as Cancer Research Technology Limited and AstraZeneca AB. His experience in these esteemed companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Matt has collaborated with notable colleagues, including Johannes Wilhelmus Maria Nissink and Maurice Raymond Verschoyle Finlay. These partnerships have enriched his work and fostered an environment of shared knowledge and innovation.

Conclusion

In summary, Matt Wood is a dedicated inventor whose work in developing cancer treatment compounds demonstrates his commitment to improving healthcare. His contributions are a testament to the importance of innovation in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…